Cleared Special

K210629 - SecurAcath (FDA 510(k) Clearance)

Apr 2021
Decision
41d
Days
Class 2
Risk

K210629 is an FDA 510(k) clearance for the SecurAcath. This device is classified as a Implanted Subcutaneous Securement Catheter (Class II - Special Controls, product code OKC).

Submitted by Interrad Medical, Inc. (Plymouth, US). The FDA issued a Cleared decision on April 12, 2021, 41 days after receiving the submission on March 2, 2021.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5970. Access To Central Venous System For Blood Sampling And Infusion, And To Provide A Means To Secure The Catheter Via A Subcutaneous Anchor Below The Insertion Site..

Submission Details

510(k) Number K210629 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 02, 2021
Decision Date April 12, 2021
Days to Decision 41 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code OKC - Implanted Subcutaneous Securement Catheter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5970
Definition Access To Central Venous System For Blood Sampling And Infusion, And To Provide A Means To Secure The Catheter Via A Subcutaneous Anchor Below The Insertion Site.